Matthew Buckhalter Sells 13,167 Shares of Aveanna Healthcare (NASDAQ:AVAH) Stock

Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) CFO Matthew Buckhalter sold 13,167 shares of the business’s stock in a transaction on Wednesday, February 18th. The shares were sold at an average price of $7.38, for a total value of $97,172.46. Following the completion of the sale, the chief financial officer directly owned 542,755 shares in the company, valued at approximately $4,005,531.90. This represents a 2.37% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link.

Matthew Buckhalter also recently made the following trade(s):

• On Thursday, February 19th, Matthew Buckhalter sold 13,512 shares of Aveanna Healthcare stock. The stock was sold at an average price of $7.21, for a total value of $97,421.52.
• On Tuesday, February 17th, Matthew Buckhalter sold 9,351 shares of Aveanna Healthcare stock. The shares were sold at an average price of $7.65, for a total transaction of $71,535.15.
• On Friday, January 2nd, Matthew Buckhalter sold 18,340 shares of Aveanna Healthcare stock. The stock was sold at an average price of $7.85, for a total transaction of $143,969.00.
• On Wednesday, December 31st, Matthew Buckhalter sold 17,289 shares of Aveanna Healthcare stock. The stock was sold at an average price of $8.18, for a total transaction of $141,424.02.
• On Tuesday, December 30th, Matthew Buckhalter sold 17,448 shares of Aveanna Healthcare stock. The shares were sold at an average price of $8.36, for a total transaction of $145,865.28.

Aveanna Healthcare Price Performance

Aveanna Healthcare stock traded up $0.02 during trading hours on Thursday, hitting $7.42. 3,877,110 shares of the stock were exchanged, compared to its average volume of 938,081. The stock has a market capitalization of $1.55 billion, a P/E ratio of 20.61 and a beta of 2.06. The business’s 50-day moving average is $8.48 and its two-hundred day moving average is $8.44. The company has a debt-to-equity ratio of 140.39, a quick ratio of 1.23 and a current ratio of 1.23. Aveanna Healthcare Holdings Inc. has a 12 month low of $3.67 and a 12 month high of $10.32.

Aveanna Healthcare News Roundup

Here are the key news stories impacting Aveanna Healthcare this week:

• Neutral Sentiment: Short-interest data released for Feb. 19 shows an apparent data anomaly (0 shares reported / NaN change), so there’s no clear short‑interest signal to explain price moves today. (Report notes the short‑interest ratio is effectively 0 days based on reported volume.)
• Neutral Sentiment: Market commentary explains recent intraday weakness in AVAH; see a recent write‑up for context on why the stock moved. Why AVAH is Down
• Negative Sentiment: Significant insider selling: over Feb. 17–19 multiple insiders (CEO Jeff Shaner, several executives including CFO Matthew Buckhalter and CAO Deborah Stewart, plus others such as Edwin C. Reisz and Patrick A. Cunningham) sold large blocks. Combined, these filings show roughly 740,000 shares sold across the group — about $5.4–$5.5M in proceeds — at average prices in the ~$7.20–$7.65 range. Collective, high‑profile sales of this size often weigh on near‑term investor sentiment because they increase supply and may be interpreted as insiders taking money off the table. CEO Filings Other Exec Filings

Institutional Trading of Aveanna Healthcare

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Quantbot Technologies LP acquired a new position in Aveanna Healthcare during the 2nd quarter valued at about $43,000. MQS Management LLC acquired a new stake in shares of Aveanna Healthcare during the 2nd quarter worth approximately $59,000. Belvedere Trading LLC bought a new stake in shares of Aveanna Healthcare during the second quarter worth approximately $62,000. Oxford Asset Management LLP acquired a new position in Aveanna Healthcare in the second quarter valued at approximately $64,000. Finally, Dynamic Technology Lab Private Ltd bought a new position in Aveanna Healthcare in the second quarter valued at approximately $68,000. 87.96% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

Several equities analysts have issued reports on AVAH shares. BMO Capital Markets began coverage on Aveanna Healthcare in a research report on Thursday, November 13th. They issued an “outperform” rating and a $11.00 price objective for the company. Truist Financial lifted their price target on Aveanna Healthcare from $9.50 to $10.00 and gave the company a “hold” rating in a report on Friday, November 7th. UBS Group upped their price target on shares of Aveanna Healthcare from $9.50 to $10.00 and gave the stock a “neutral” rating in a research report on Thursday, January 15th. Royal Bank Of Canada raised their price objective on shares of Aveanna Healthcare from $10.00 to $11.00 and gave the company a “sector perform” rating in a research report on Thursday, January 15th. Finally, Weiss Ratings reiterated a “hold (c+)” rating on shares of Aveanna Healthcare in a research report on Monday, December 29th. Five equities research analysts have rated the stock with a Buy rating and six have issued a Hold rating to the company. According to data from MarketBeat, Aveanna Healthcare presently has an average rating of “Hold” and an average target price of $11.06.

Aveanna Healthcare Company Profile

Aveanna Healthcare, Inc (NASDAQ: AVAH) is a national provider of in-home health care services, specializing in pediatric skilled nursing, therapy, and related support for medically complex and chronically ill children. The company delivers a range of clinical and therapeutic solutions designed to enable patients to receive care in the comfort of their own homes, reducing the need for hospital stays and long-term institutional care. Aveanna’s offerings include registered nursing, physical, occupational and speech therapy, behavioral health counseling, and durable medical equipment coordination.

In addition to pediatric home health services, Aveanna operates adult home health and personal care support programs, assisting elderly and disabled adults with daily living activities, medication management, and rehabilitation therapies.